NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) — Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine firm, has appointed licensed private care and wellness doctor and psychiatrist, Dr. Anthony Puopolo, to the brand new place of chief medical officer.
Dr. Puopolo might be answerable for overseeing the corporate’s quickly increasing community of state licensed physicians and making certain that the corporate is delivering the very best high quality of care. He will even work carefully with Conversion Labs’ product and advertising groups to optimize the corporate’s telemedicine choices and help growth into new verticals.
Dr. Puopolo brings to Conversion Labs greater than 20 years of govt {and professional} healthcare expertise, together with serving in senior management positions at a number of medical establishments and organizations. He most not too long ago served because the regional medical director for SwiftMD, which gives customized telemedicine companies to people, teams and employers.
“We’re lucky to have discovered an achieved doctor like Dr. Puopolo with a various background in major care, psychological well being and integrative medication,” acknowledged Justin Schreiber, CEO of Conversion Labs. “Along with his expertise in practising medication, Dr. Puopolo is a pioneer and entrepreneur within the telemedicine world with a deep understanding of how one can handle the supply of digital medical care. Dr. Puopolo’s expertise and management provides large worth to our group as our affected person inhabitants and doctor community each proceed to develop.”
Dr. Puopolo based Integrative Wellness Medical Group the place he specialised in wellness teaching, pharmacological administration and psychotherapy. He beforehand served as a doctor at Sharp Rees Stealy Medical Group, the place he supplied to greater than 2,000 sufferers an individual-focused method to well being care.
Dr. Puopolo accomplished an intensive wellness fellowship with the acclaimed Dr. Andrew Weil, the founder and director of the Andrew Weil Middle for Integrative Medication on the College of Arizona. Working alongside Dr. Weil, he acquired in-depth coaching on strain-counterstain methods, natural medicines and dietary dietary supplements, dietary schooling and way of life medication.
“I’m excited to affix Conversion Labs, one of many world’s quickest rising telemedicine corporations, as a result of the way it so successfully makes use of telemedicine to assist sufferers enhance their well being and wellbeing,” stated Dr. Puopolo. “I look ahead to utilizing my information in medication and wellness to assist fulfill this necessary mission.”
Dr. Puopolo earlier served in a number of positions at 121 Basic Hospital in South Korea, together with as chief of inpatient psychiatric ward, medical director of its alcohol remedy heart, and as a household apply employees doctor. As an Military Main, he served because the chief psychiatrist and officer-in-charge on the U.S. Military’s Camp Casey Troop Medical Clinic in South Korea which supplied psychological well being companies to the twond Infantry Division.
He earned his B.A. in Biology from Tufts College, M.A. in Biology from Boston College, and Physician of Medication from the Boston College Faculty of Medication. He accomplished his residency on the Tripler Military Medical Middle, the most important Military medical remedy facility within the Pacific Basin, the place he acquired the Military C.A.R.E.S Award for “caring, attentive, responsive, empathetic, and supportive care.”
Dr. Puopolo is a member of the American Board of Household Medication and Eye Motion Desensitization Reprocessing Worldwide Affiliation (EMDRIA).
About Conversion Labs
Conversion Labs, Inc. is a telemedicine firm with a portfolio of on-line direct-to-consumer manufacturers. The corporate’s manufacturers mix digital medical remedy with prescription medicines and distinctive over-the-counter merchandise. Its community of licensed physicians provides telemedicine companies and direct-to-consumer pharmacy to shoppers throughout the U.S. To study extra, go to Conversionlabs.com.
Vital Cautions Concerning Ahead-Trying Statements
This information launch contains forward-looking statements throughout the that means of Part 27A of the Securities Act of 1933 and Part 21E of the Securities Alternate Act of 1934, as amended, relating to, amongst different issues our plans, methods and prospects — each enterprise and monetary. Though we imagine that our plans, intentions and expectations mirrored in or instructed by these forward-looking statements are cheap, we can’t guarantee you that we’ll obtain or notice these plans, intentions or expectations. Ahead-looking statements are inherently topic to dangers, uncertainties and assumptions. Most of the forward-looking statements contained on this information launch could also be recognized by means of forward-looking phrases similar to “imagine,” “anticipate,” “anticipate,” “ought to,” “deliberate,” “will,” “might,” “intend,” “estimated,” and “potential,” amongst others. Vital components that might trigger precise outcomes to vary materially from the forward-looking statements we make on this information launch embrace market circumstances and people set forth in studies or paperwork that we file every so often with the USA Securities and Alternate Fee. All forward-looking statements attributable to Conversion Labs, Inc. or an individual performing on its behalf are expressly certified of their entirety by this cautionary language.
Firm Contact
Conversion Labs
Juan Manuel Piñeiro Dagnery
CFO
Email Contact
Media and Investor Relations Contact
Ron Each or Grant Stude
CMA Investor Relations
Tel (949) 432-7566
Email Contact
Source link
